Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C J Wikstrand

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Genome Research|September 14, 2000
Identifying potential tumor markers and antigens by database mining and rapid expression screeningW T Loging, A Lal, I M Siu, et al.
Journal of Neurochemistry|October 1, 1990
Determination of gangliosides in six human primary medulloblastomasJ Gottfries, P Fredman, J E Månsson, et al.
Journal of Neuropathology and Experimental Neurology|January 1, 1989
Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenograftsX M He, S X Skapek, C J Wikstrand, et al.
Cancer Research|October 1, 1995
Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenograftsC J Reist, G E Archer, S N Kurpad, et al.
Cancer|May 4, 2001
Long term response in a patient with neoplastic meningitis secondary to melanoma treated with (131)I-radiolabeled antichondroitin proteoglycan sulfate Mel-14 F(ab')(2): a case studyI Cokgor, G Akabani, H S Friedman, et al.
Journal of Neuroimmunology|May 1, 1987
Comparative localization of glioma-reactive monoclonal antibodies in vivo in an athymic mouse human glioma xenograft modelC J Wikstrand, R E McLendon, S Carrel, et al.
Cancer Research|July 15, 1995
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomasC J Wikstrand, L P Hale, S K Batra, et al.
Journal of Neuro-Oncology|January 1, 1995
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary reportD D Bigner, M Brown, R E Coleman, et al.
Cancer Research|March 1, 1992
Expression of O6-methylguanine-DNA methyltransferase in six human medulloblastoma cell linesX M He, L E Ostrowski, M A von Wronski, et al.
The American Journal of Pathology|March 1, 1988
Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-mycH S Friedman, P C Burger, S H Bigner, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Genome Research|September 14, 2000
Identifying potential tumor markers and antigens by database mining and rapid expression screeningW T Loging, A Lal, I M Siu, et al.
Journal of Neurochemistry|October 1, 1990
Determination of gangliosides in six human primary medulloblastomasJ Gottfries, P Fredman, J E Månsson, et al.
Journal of Neuropathology and Experimental Neurology|January 1, 1989
Phenotypic analysis of four human medulloblastoma cell lines and transplantable xenograftsX M He, S X Skapek, C J Wikstrand, et al.
Cancer Research|October 1, 1995
Tumor-specific anti-epidermal growth factor receptor variant III monoclonal antibodies: use of the tyramine-cellobiose radioiodination method enhances cellular retention and uptake in tumor xenograftsC J Reist, G E Archer, S N Kurpad, et al.
Cancer|May 4, 2001
Long term response in a patient with neoplastic meningitis secondary to melanoma treated with (131)I-radiolabeled antichondroitin proteoglycan sulfate Mel-14 F(ab')(2): a case studyI Cokgor, G Akabani, H S Friedman, et al.
Journal of Neuroimmunology|May 1, 1987
Comparative localization of glioma-reactive monoclonal antibodies in vivo in an athymic mouse human glioma xenograft modelC J Wikstrand, R E McLendon, S Carrel, et al.
Cancer Research|July 15, 1995
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomasC J Wikstrand, L P Hale, S K Batra, et al.
Journal of Neuro-Oncology|January 1, 1995
Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary reportD D Bigner, M Brown, R E Coleman, et al.
Cancer Research|March 1, 1992
Expression of O6-methylguanine-DNA methyltransferase in six human medulloblastoma cell linesX M He, L E Ostrowski, M A von Wronski, et al.
The American Journal of Pathology|March 1, 1988
Phenotypic and genotypic analysis of a human medulloblastoma cell line and transplantable xenograft (D341 Med) demonstrating amplification of c-mycH S Friedman, P C Burger, S H Bigner, et al.
Pageof 9